These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3063653)

  • 21. Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension.
    Cugini P; Serdoz R; Manconi R; Mancini A; Meucci T
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):111-5. PubMed ID: 737057
    [No Abstract]   [Full Text] [Related]  

  • 22. The renin-angiotensin system in hypothyroidism of short duration.
    Elias AN; Kyaw T; Valenta LJ; Meshkinpour H
    Horm Metab Res; 1986 May; 18(5):349-51. PubMed ID: 3522392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
    Vierhapper H; Waldhäusl W
    Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
    Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
    Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic variations of plasma renin and aldosterone during active orthostatism in three subtypes of essential hypertension.
    Cugini P; Manconi R; Serdoz R; Mancini A; Meucci T
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):116-21. PubMed ID: 737058
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects.
    Campese VM; Romoff M; DeQuattro V; Massry SG
    J Lab Clin Med; 1980 Jun; 95(6):927-33. PubMed ID: 6991621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between plasma volume and plasma renin activity, aldosteronemia, blood electrolytes and arterial pressure in a group of randomized hypertensives].
    Cerasola GA; Amico LM; Botta RM; D'Alessandro E; Morici ML
    Boll Soc Ital Cardiol; 1979; 24(5):501-8. PubMed ID: 399853
    [No Abstract]   [Full Text] [Related]  

  • 29. [Plasma levels of catecholamine, renin activity and aldosterone during operations in patients with hypertension].
    Nakamura H; Kono K; Okutani R; Shibata O; Haseba S; Ishida H; Gotoh Y
    Masui; 1988 Feb; 37(2):157-62. PubMed ID: 3286921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of plasma levels of renin and aldosterone activity in essential arterial hypertension in relation to duration of the disease and the presence of complications].
    Scavo D; Cugini P; Manconi R; Serdoz R
    Boll Soc Ital Cardiol; 1977; 22(8):1389-95. PubMed ID: 156037
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasopressin and renin-aldosterone system in patients with arterial hypertension].
    Kasenova SL
    Klin Med (Mosk); 2002; 80(12):31-4. PubMed ID: 12638408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nyctohemeral values of plasma renin and aldosterone in relation to age, sex and sodium intake and posture].
    Cugini P; Lucia P; Murano G; Centanni M; Letizia C; Scavo D
    Cardiologia; 1983 Jul; 28(7):559-68. PubMed ID: 6378223
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pattern of aldosterone and catecholamines in patients with essential hypertension and differnet plasma renin activity].
    Ignatowska-Switalska H; Wocial B; Feltynowski T; Zukowska-Grójec Z
    Pol Tyg Lek; 1977 Jul; 32(28):1069-72. PubMed ID: 887493
    [No Abstract]   [Full Text] [Related]  

  • 34. Age and the renin-aldosterone system.
    Noth RH; Lassman MN; Tan SY; Fernandez-Cruz A; Mulrow PJ
    Arch Intern Med; 1977 Oct; 137(10):1414-7. PubMed ID: 921422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma levels of aldosterone and ACTH and renin activity during spinal anesthesia and surgery].
    Taniguchi K; Kudo T; Oyama T
    Masui; 1977 May; 26(5):554-9. PubMed ID: 196122
    [No Abstract]   [Full Text] [Related]  

  • 36. The integrated concentration of plasma renin activity and aldosterone in essential hypertension.
    Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP
    Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of plasma aldosterone in infancy and childhood. A study of plasma renin activity, plasma cortisol and plasma aldosterone.
    Stark P; Beckerhoff R; Leumann EP; Vetter W; Siegenthaler W
    Helv Paediatr Acta; 1976 Jan; 30(4-5):349-56. PubMed ID: 1245434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma renin activity, aldosterone and aging: chronobiological circadian study].
    Natali G; Casale R; Colantonio D; Pasqualetti P
    Recenti Prog Med; 1988 Nov; 79(11):460-2. PubMed ID: 3068739
    [No Abstract]   [Full Text] [Related]  

  • 39. [Individual renal blood flow and activity of the renin-aldosterone system in patients with renovascular hypertension and hypertensive disease].
    Kutsenko AI; Shpil'kin VM; Rossel's AN; Eliseeva NA; Belianin VI
    Vestn Akad Med Nauk SSSR; 1978; (10):82-9. PubMed ID: 706726
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocrine effects of lithium. III. Hypermagnesaemia and activation of the renin-aldosterone system.
    Transbøl I; Christiansen C; Baastrup PC; Nielsen MD; Giese J
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):619-24. PubMed ID: 581026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.